Voyager Therapeutics, Inc. (VYGR)
NASDAQ: VYGR · Real-Time Price · USD
3.800
+0.080 (2.15%)
Aug 15, 2025, 10:42 AM - Market open
Voyager Therapeutics Market Cap
Voyager Therapeutics has a market cap or net worth of $210.78 million as of August 15, 2025. Its market cap has decreased by -57.51% in one year.
Market Cap
210.78M
Enterprise Value
-15.49M
1-Year Change
-57.51%
Ranking
Category
Stock Price
$3.80
Market Cap Chart
Since November 11, 2015, Voyager Therapeutics's market cap has decreased from $456.60M to $210.78M, a decrease of -53.84%. That is a compound annual growth rate of -7.61%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Aug 13, 2025 | 202.50M | -34.61% |
| Dec 31, 2024 | 309.70M | -16.59% |
| Dec 29, 2023 | 371.30M | 57.66% |
| Dec 30, 2022 | 235.50M | 128.86% |
| Dec 31, 2021 | 102.90M | -61.59% |
| Dec 31, 2020 | 267.90M | -48.20% |
| Dec 31, 2019 | 517.20M | 69.02% |
| Dec 31, 2018 | 306.00M | -31.60% |
| Dec 29, 2017 | 447.40M | 31.43% |
| Dec 30, 2016 | 340.40M | -41.89% |
| Dec 31, 2015 | 585.80M | 28.30% |
| Nov 11, 2015 | 456.60M | - |
View and export this data all the way back to 2015. Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 592.16B |
| Johnson & Johnson | 419.05B |
| AbbVie | 353.86B |
| UnitedHealth Group | 245.19B |
| AstraZeneca | 232.33B |
| Novartis AG | 230.64B |
| Abbott Laboratories | 224.54B |
| Novo Nordisk | 223.00B |